FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Topiramate | Topiramate 100 mg/1 | Capsule, Extended releaseOral | Cranbury Pharmaceuticals, LLC | Oct 1, 2026 | 27808-327 |
| Topiramate | Topiramate 150 mg/1 | Capsule, Extended releaseOral | Cranbury Pharmaceuticals, LLC | Oct 1, 2026 | 27808-328 |
| Topiramate | Topiramate 200 mg/1 | Capsule, Extended releaseOral | Cranbury Pharmaceuticals, LLC | Oct 1, 2026 | 27808-329 |
| Trentalpentoxifylline | Pentoxifylline 400 mg/1 | Tablet, Extended releaseOral | Validus Pharmaceuticals LLC | Oct 1, 2026 | 30698-006 |
| Dapagliflozin | Dapagliflozin 5 mg/1 | TabletOral | Micro Labs Limited | Oct 1, 2026 | 42571-317 |
| Dapagliflozin | Dapagliflozin 10 mg/1 | TabletOral | Micro Labs Limited | Oct 1, 2026 | 42571-318 |
| Dapagliflozin and Metformin Hydrochloride | Dapagliflozin 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | Micro Labs Limited | Oct 1, 2026 | 42571-320 |
| Dapagliflozin and Metformin Hydrochloride | Dapagliflozin 10 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | Micro Labs Limited | Oct 1, 2026 | 42571-321 |
| Dapagliflozin and Metformin Hydrochloride | Dapagliflozin 5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Micro Labs Limited | Oct 1, 2026 | 42571-322 |
| Dapagliflozin and Metformin Hydrochloride | Dapagliflozin 10 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Micro Labs Limited | Oct 1, 2026 | 42571-323 |
| Gwyn Lonorelgestromin and ethinyl estradiol | Norelgestromin 220 ug/d; Ethinyl estradiol 20 ug/d | PatchTransdermal | Viatris Specialty LLC | Oct 1, 2026 | 49502-627 |
| Ertapenemertapenem sodium | Ertapenem sodium 1 g/20mL | InjectionIntramuscular, Intravenous | Apotex Corp | Oct 1, 2026 | 60505-4956 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | American Health Packaging | Oct 1, 2026 | 60687-961 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | American Health Packaging | Oct 1, 2026 | 60687-972 |
| Methotrexate | Methotrexate 2.5 mg/1 | TabletOral | American Health Packaging | Oct 1, 2026 | 60687-975 |
| Nicardipine Hydrochloride | Nicardipine hydrochloride .1 mg/mL | InjectionIntravenous | Fresenius Kabi USA, LLC | Oct 1, 2026 | 65219-296 |
| Nicardipine Hydrochloride | Nicardipine hydrochloride .2 mg/mL | InjectionIntravenous | Fresenius Kabi USA, LLC | Oct 1, 2026 | 65219-298 |
| Hercessitrastuzumab-strf | — | Kit | Accord BioPharma Inc. | Oct 1, 2026 | 69448-035 |
| Rivaroxaban | Rivaroxaban 2.5 mg/1 | TabletOral | Lifestar Pharma LLC | Oct 1, 2026 | 70756-006 |
| Thiamine Hydrochloride | Thiamine hydrochloride 100 mg/mL | Injection, SolutionIntramuscular, Intravenous | Lifestar Pharma LLC | Oct 1, 2026 | 70756-684 |
| Tretinoin | Tretinoin .25 mg/g | CreamTopical | Zydus Lifesciences Limited | Oct 1, 2026 | 70771-1933 |
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | ANI Pharmaceuticals, Inc. | Oct 1, 2026 | 70954-025 |
| Fosfomycin Tromethamine | Fosfomycin tromethamine 3 g/1 | Granule, For solutionOral | ANI Pharmaceuticals, Inc. | Oct 1, 2026 | 70954-040 |
| Tretinoin | Tretinoin .25 mg/g | CreamTopical | Viona Pharmaceuticals Inc | Oct 1, 2026 | 72578-155 |
| Famotidine | Famotidine 40 mg/5mL | Powder, For suspensionOral | NorthStar Rx LLC | Oct 1, 2026 | 72603-564 |